Table 1: Socio-demographic and clinical characteristics of hemodialysis patients on at 3rd and 15th month follow-ups.
| Variables N (%) | G1 31 (55.4) | G2 25 (44.6) | p |
| Age | 0.014* | ||
| Mean ± SD | 62.9 ± 16.7 | 52.8 ± 13.0 | |
| Median | 69 | 53 | |
| Variation | 23-83 | 24-75 | |
| Gender | 0.389 | ||
| Female | 9 (29.0) | 10 (40.0) | |
| Male | 22 (71.0) | 15 (60.0) | |
| Race | 0.315 | ||
| White | 27 (87.1) | 19 (76.0) | |
| Non White | 4 (12.9) | 6 (24.0) | |
| Social Class | 0.179 | ||
| A + B | 18 (58.1) | 10 (40.0) | |
| C + D + E | 13 (41.9) | 15 (60.0) | |
| Type of Initial Access | 0.241 | ||
| AVF | 19 (61.3) | 19 (76.0) | |
| Indwelling catheter | 12 (38.7) | 6 (24.0) | |
| Type of Final Accessa | 0.478 | ||
| AVF | 17 (68.0) | 13 (81.3) | |
| Indwelling catheter | 8 (32.0) | 3 (18.7) | |
| CKD Ethiology | |||
| Hypertensive Nephrosclerosis | 7 (22.6) | 3 (12.0) | |
| Diabetic Nephropathy | 2 (6.4) | 5 (20.0) | |
| DM + SAH | 3 (9.7) | 5 (20.0) | |
| Other Causes | 8 (25.8) | 7 (28.0) | |
| Unknown Etiology | 11 (35.5) | 5 (20.0) | |
| Comorbidities | |||
| Absence of Comorbidities | 0 (0.0) | 2 (8.0) | |
| Hypertension | 12 (38.7) | 5 (20.0) | |
| Diabetes | 0 (0.0) | 1 (4.0) | |
| Cardiovascular Diseases | 1 (3.3) | 0 (0.0) | |
| DM + SAH | 5 (16.1) | 3 (12.0) | |
| DM + SAH + CVDs | 4 (12.9) | 8 (32.0) | |
| SAH + CVDs | 9 (29.0) | 6 (24.00) | |
| Nº of Comorbidities | |||
| 0 + 1 | 12 (38.7) | 8 (32.0) | 0.602 |
| 2 or + | 19 (61.3) | 17 (68.0) | |
| Nº of Hospitalizations (days) | 0.028* | ||
| Mean ± SD | 5.23 ± 11 | 14.3 ± 22.21 | |
| Median | 0 | 5.0 | |
| Variation | 0-43 | 0-100 |
Symbols and abbreviations: *: Statistically significant p value; a: 41 patients completed the study; G1: Group with full nutritional assistance; G2: Group with partial nutritional assistance; N: Number of patients; AVF: Arteriovenous fistula; DM: Diabetes mellitus; SAH: Systemic arterial hypertension; CVD (s): Cardiovascular disease (s); Tests used: Age ("t"-Student test), Gender, Social Class, Type of initial access, Nº of comorbidities (chi-square), Race, Type of final access (Fisher's exact test), Nº of days of hospitalization (Mann-Whitney).